Houston, TXNCT06181656Now EnrollingIRB Ready

Pneumococcal Vaccine Clinical Trial in Houston, TX

Access cutting-edge pneumococcal vaccine treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by M.D. Anderson Cancer Center

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access pneumococcal vaccine specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pneumococcal vaccine treatment provided free

Apply for This Houston Location

Check if you qualify for this pneumococcal vaccine clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Pneumococcal Vaccine Study in Houston

To learn how radiation treatment may affect your responses to vaccines against pneumonia.

Sponsor: M.D. Anderson Cancer Center

Who Can Participate

Inclusion Criteria

Group 1A a. Patients currently receiving, planning to receive, or recently completed chemoradiation for esophageal cancer with protons.
Group 1B a. Patients currently receiving, planning to receive, or recently completed chemoradiation for esophageal cancer with intensity-modulated radiation therapy (IMRT)
Group 2A a. Patients currently receiving, planning to receive, or recently completed definitive proton therapy for unresectable liver cancer.
Group 2B a. Patients currently receiving, planning to receive, or recently completed definitive IMRT for unresectable liver cancer.
Group 3 a. Healthy age- and gender- matched individuals
Patients of all genders, races and nationalities will be solicited.
Age \>18 years
Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria

Patients with compromised immunologic responses due to an uncontrolled intercurrent immunodeficiency (e.g., Human immunodeficiency virus (HIV), X-linked agammaglobulinemia) or previous or current immune suppressive therapy a. Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial.
Patients receiving intravenous immunoglobulin (IVIG) during the study or in the three months prior to study enrollment.
Patients with psychiatric illness/social situations that would limit compliance with study requirements.
Individuals with previous pneumococcal vaccination in the last 5 years.
Individuals with severe allergy to any of the vaccine components

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT06181656) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pneumococcal Vaccine Treatment Options in Houston, TX

If you're searching for pneumococcal vaccine treatment options in Houston, TX, this clinical trial (NCT06181656) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pneumococcal vaccine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pneumococcal vaccine clinical trials near you to find additional studies recruiting in your area.

More Prurigo Nodularis Trials in Houston, TX

See all prurigo nodularis clinical trials recruiting in Houston — not just this study.

Browse Prurigo Nodularis Trials in Houston →

Browse More Trials by Condition

Prurigo Nodularis TrialsVaccine TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX